Major randomized controlled trials, such as the UKCTOCS, have demonstrated that population screening does not significantly reduce ovarian cancer mortality, and as a result, routine screening is not recommended for the general public.
Evidence for · 2
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
2025 · cited by 3
The large UKCTOCS randomized controlled trial established that population screening for ovarian cancer does not significantly reduce disease-specific deaths, leading to the conclusion that general population screening cannot be recommended.
See more details
More for · 1
Advances in ovarian cancer screening and early detection: from biomarkers to multivariate index assays.
2026 · cited by 1
Recent clinical literature affirms that existing modalities lack sufficient sensitivity and specificity, and no ovarian cancer screening test is currently approved for routine use.